Interventional oncology is a rapidly growing field of interventional oncology which deals with diagnosis and treatment of cancer using minimally invasive procedures. It uses various imaging techniques such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. Interventional oncology is generally employed for treatment of liver cancer, lung cancer, bone cancer, kidney cancer, prostate cancer, breast cancer, and pancreatic cancer. Interventional oncology treatment market is segmented into Radiation therapy, Ablation, and Particle embolization on the basis of procedure.

Interventional oncology is expected to become the fourth pillar of cancer care, with medical, surgical, and radiation oncology. It provides with minimally invasive treatment option while mitigating various associated risks. Growth of the global interventional oncology market is propelled by rising oncology incidences, growing demand for minimally invasive therapeutics and increasing geriatric population. However, the market faces several challenges due to high treatment cost, associated risk, and the presence of alternative treatment options.

The report “Global Interventional Oncology Market – (By Therapy – Radiation Therapy, Particle Embolization & Ablation; By Region- North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global interventional oncology market with coverage on major market segments such as Radiation Therapy, Particle Embolization & Ablation. Future forecasts of interventional oncology market overall and across various market segments have been provided in the report till 2025. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global interventional oncology market include Boston Scientific Corporation, Accuray Incorporated, Medtronic PLC, Terumo Corporation, Merit Medical Systems, Inc., BTG PLC, among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global interventional oncology market.

Key Factors Impacting Market Growth:

  • Rising oncology incidences
  • Growing demand for minimally invasive therapeutics
  • Increasing geriatric population

What Does This Report Provide?

This report provides a detailed understanding of the global interventional oncology market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Therapy:

  • Radiation Therapy
  • Particle Embolization
  • Ablation

By Region:

  • North America
    • By Therapy
  • Europe
    • By Therapy
  • Asia Pacific
    • By Therapy
  • Rest of the World
    • By Therapy

Companies Covered: Boston Scientific Corporation, Accuray Incorporated, Medtronic PLC, Terumo Corporation, Merit Medical Systems, Inc., BTG PLC 

Reasons To Buy This Report:

  • Market size estimation of the Global Interventional Oncology market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offerings

Single User License - USD 3999

Multi User License - USD 5499

Corporate License - USD 6999

Why QMI?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

Close Menu